Arnatar Therapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$52M
- Investors
-
12
Arnatar Therapeutics General Information
Description
Developer of programmable RNA (Ribonucleic Acid) therapeutics designed to deliver precision therapies that restore protein function and offer long-term disease control. The company combines siRNA-based gene silencing and ASO-based protein upregulation, developing nucleic acid drugs for liver-targeted and extrahepatic-targeted metabolic and rare diseases, enabling healthcare organizations to access therapeutic approaches across cardiovascular, metabolic, CNS, and rare diseases.
Contact Information
Website
www.arnatar.comCorporate Office
- 10355 Science Center Drive
- Suite 130
- San Diego, CA 92121
- United States
Corporate Office
- 10355 Science Center Drive
- Suite 130
- San Diego, CA 92121
- United States
Arnatar Therapeutics Timeline
Arnatar Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 08-Apr-2024 | $52M | Completed | Clinical Trials - Phase 1 | ||
| 1. Seed Round | 19-Sep-2022 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Arnatar Therapeutics Comparisons
Industry
Financing
Details
Arnatar Therapeutics Competitors (122)
One of Arnatar Therapeutics’s 122 competitors is STORM Therapeutics, a Venture Capital-Backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| STORM Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Aro Biotherapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| Cognition Therapeutics | Formerly VC-backed | New York, NY | ||||
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Repertoire Immune Medicines | Venture Capital-Backed | Cambridge, MA |
Arnatar Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Arnatar Therapeutics Patents
Arnatar Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4592432-A2 | Arnatar compounds and methods for enhanced cellular uptake | Pending | 19-Dec-2022 | ||
| EP-4592432-A3 | Arnatar compounds and methods for enhanced cellular uptake | Pending | 19-Dec-2022 |
Arnatar Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Arnatar Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3E Bioventures (China) | Venture Capital | Minority | ||
| Eight Roads | Corporate Venture Capital | Minority | ||
| F-Prime | Venture Capital | Minority | ||
| Gaorong Ventures | Venture Capital | Minority | ||
| Jifeng Ventures | Venture Capital | Minority |
Arnatar Therapeutics FAQs
-
When was Arnatar Therapeutics founded?
Arnatar Therapeutics was founded in 2022.
-
Where is Arnatar Therapeutics headquartered?
Arnatar Therapeutics is headquartered in San Diego, CA.
-
What is the size of Arnatar Therapeutics?
Arnatar Therapeutics has 21 total employees.
-
What industry is Arnatar Therapeutics in?
Arnatar Therapeutics’s primary industry is Drug Discovery.
-
Is Arnatar Therapeutics a private or public company?
Arnatar Therapeutics is a Private company.
-
What is Arnatar Therapeutics’s current revenue?
The current revenue for Arnatar Therapeutics is .
-
How much funding has Arnatar Therapeutics raised over time?
Arnatar Therapeutics has raised $62M.
-
Who are Arnatar Therapeutics’s investors?
3E Bioventures (China), Eight Roads, F-Prime, Gaorong Ventures, and Jifeng Ventures are 5 of 12 investors who have invested in Arnatar Therapeutics.
-
Who are Arnatar Therapeutics’s competitors?
STORM Therapeutics, Aro Biotherapeutics, Cognition Therapeutics, AnTolRx, and Repertoire Immune Medicines are some of the 122 competitors of Arnatar Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
